Market revenue in 2022 | USD 536.6 million |
Market revenue in 2030 | USD 1,423.6 million |
Growth rate | 13% (CAGR from 2022 to 2030) |
Largest segment | Multi dose |
Fastest growing segment | Multi dose |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Multi dose, Single dose |
Key market players worldwide | Amcor PLC, West Pharmaceutical Services Inc, Gerresheimer AG ADR, Schott Pharma AG & CO KGaA, AptarGroup Inc, BD |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic packaging market will help companies and investors design strategic landscapes.
Multi dose was the largest segment with a revenue share of 72.1% in 2022. Horizon Databook has segmented the Japan ophthalmic packaging market based on multi dose, single dose covering the revenue growth of each sub-segment from 2017 to 2030.
Japan is one of the major pharmaceutical markets globally. The increase in aging population is raising government healthcare expenditure in the country. The Japanese pharmaceutical industry has opened up to foreign markets and international companies running operations in the country, over the past decades, and we anticipate the trend to continue through the forecast period.
Japan is one of the most important markets for pharmaceuticals, including ophthalmic, globally. The high growth of Japanese ophthalmic market is estimated to pave way for the ophthalmic packaging market. The reimbursement barrier is relatively lower compared to EU markets, which is also an important factor that augments the pharmaceutical market in Japan.
However, a few factors that may hamper the overall growth of Japan’s pharma industry are practice of biennial price cuts and increasing generics uptake. New drug research & development and high-quality products are some of the competitive advantages in the Japanese ophthalmic industry.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan ophthalmic packaging market, including forecasts for subscribers. This country databook contains high-level insights into Japan ophthalmic packaging market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account